SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-298152
Filing Date
2023-12-19
Accepted
2023-12-19 07:31:02
Documents
41
Period of Report
2023-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d648703d8k.htm   iXBRL 8-K 239238
2 EX-3.1 d648703dex31.htm EX-3.1 8682
3 EX-3.2 d648703dex32.htm EX-3.2 23782
4 EX-3.3 d648703dex33.htm EX-3.3 128873
5 EX-10.6 d648703dex106.htm EX-10.6 128478
6 EX-10.19 d648703dex1019.htm EX-10.19 23367
7 EX-10.20 d648703dex1020.htm EX-10.20 49971
8 EX-10.21 d648703dex1021.htm EX-10.21 138049
9 EX-10.22 d648703dex1022.htm EX-10.22 84925
10 EX-10.23 d648703dex1023.htm EX-10.23 42077
11 EX-10.24 d648703dex1024.htm EX-10.24 41277
12 EX-10.26 d648703dex1026.htm EX-10.26 27864
13 EX-10.27 d648703dex1027.htm EX-10.27 30362
14 EX-10.28 d648703dex1028.htm EX-10.28 12763
15 EX-10.29 d648703dex1029.htm EX-10.29 28177
16 EX-10.30 d648703dex1030.htm EX-10.30 11637
17 EX-10.31 d648703dex1031.htm EX-10.31 10866
18 EX-10.32 d648703dex1032.htm EX-10.32 11822
19 EX-10.33 d648703dex1033.htm EX-10.33 11634
20 EX-14.1 d648703dex141.htm EX-14.1 67799
21 EX-21.1 d648703dex211.htm EX-21.1 700
22 EX-23.1 d648703dex231.htm EX-23.1 1644
23 EX-99.1 d648703dex991.htm EX-99.1 29204
24 EX-99.2 d648703dex992.htm EX-99.2 17539
25 EX-99.3 d648703dex993.htm EX-99.3 376048
26 EX-99.4 d648703dex994.htm EX-99.4 205978
27 EX-99.5 d648703dex995.htm EX-99.5 265516
32 GRAPHIC g648703dsp016.jpg GRAPHIC 2793
33 GRAPHIC g648703g1216023525209.jpg GRAPHIC 2975
  Complete submission text file 0001193125-23-298152.txt   2593278

Data Files

Seq Description Document Type Size
28 XBRL TAXONOMY EXTENSION SCHEMA ngne-20231213.xsd EX-101.SCH 2749
29 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ngne-20231213_def.xml EX-101.DEF 13942
30 XBRL TAXONOMY EXTENSION LABEL LINKBASE ngne-20231213_lab.xml EX-101.LAB 23327
31 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ngne-20231213_pre.xml EX-101.PRE 14808
35 EXTRACTED XBRL INSTANCE DOCUMENT d648703d8k_htm.xml XML 5619
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 231495635
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)